Ascension-in-Focus | Shailesh Guntu been appointed as CEO of Milann & Director - Healthcare Services – HCG. His current role is to drive Milann fertility as CEO and additionally, Shailesh will continue to manage his existing responsibility as the business leader for Andhra Pradesh, North Karnataka & Africa. Milann has been redefining high-tech fertility care in India by offering individuals access to advanced medical diagnosis and treatment options available in the field of Assisted Reproduction Technology (ART). It brings together a team of highly experienced fertility experts including clinical specialists, embryologists, nurses and other healthcare workers who are specialized in the field of infertility, woman’s health and reproductive medicine with its presence across the cities like Bengaluru, Delhi NCR, Chandigarh and Ahmedabad.
Shailesh Guntu - a result-first, six sigma Green Belt healthcare veteran with nearly 16 years of mission critical expertise across a versatile function spectrum (Operations, Business Development, Customer Service & Brand management in the Service industry) - has been associated with the organization for the last 4.5 years. Prior to this new development, he was holding the prestigious rank of COO (Regional Operations & Director) at HCG, Africa. At the time of this publication, Mr. Guntu has already assumed his new role and mantle as CEO.
Headquartered in Bangalore, HCG (HealthCare Global Enterprises Ltd) is India's largest Cancer Care Provider and a physician-led initiative that owns and manages a network of 23 cancer centres nationwide. The organization also deals with clinical research and R&D. For over fifteen years, HCG Global Enterprises has been defining the future of cancer care in India by designing, building and managing cancer centres with a steadfast vision : to transform cancer care environment by bringing core clinical services to one central place.
“I am humbled and delighted to have been considered equal to the new role which comes with multiple responsibilities. At HCG, our big goal has always been to help patients achieve longer and better lives - and to improve cancer care - one innovation and one center, at a time. In my new position, I hope to add new momentum to our ongoing mission of transformation. It’s time we aimed for bigger goals and crossed grander milestones… together as a nation. ”
Mankind Pharma invests in Actimed Therapeutics, a UK based clinical stage specia
Tata Capital Healthcare Fund infuses $ 10 mn in Mumbai Oncocare Centre
MediBuddy reports 2X growth in revenues, becomes fastest growing digital healthc
Apollo Hospitals, Ahmedabad, awarded Most Preferred Workplace 2022-23
HiMedia’s COVID-19 Detection Kit detects the BF.7 variant
AHPI Gujarat Health Talk Series
A Stalwart Climbs Another Peak
Dr. Sajan appointed Group COO of Paras Healthcare
From Learning to healing : Hematological session
Cadila Pharmaceuticals signs Investment Intention Form (IIF) with Odisha Governm
Mankind Pharma acquires majority stake in Upakarma Ayurveda
Ahmedabad doctors save Mumbai civic official’s life
BEAT-O RAISES $33 MILLION
HCG Cancer Hospital Bengaluru sets a new benchmark for Personalized cancer care
WOMEN’S WELLBEING FINDS NEW CUSTODIAN
View All